Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy.

Loh WY, Piper ME, Schlam TR, Fiore MC, Smith SS, Jorenby DE, Cook JW, Bolt DM, Baker TB.

Nicotine Tob Res. 2012 Feb;14(2):131-41. doi: 10.1093/ntr/ntr147. Epub 2011 Dec 16.

2.

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.

Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL.

Ann Intern Med. 2009 Apr 7;150(7):447-54.

PMID:
19349630
3.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
4.

Why two smoking cessation agents work better than one: role of craving suppression.

Bolt DM, Piper ME, Theobald WE, Baker TB.

J Consult Clin Psychol. 2012 Feb;80(1):54-65. doi: 10.1037/a0026366. Epub 2011 Nov 21.

5.

Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.

Piper ME, Cook JW, Schlam TR, Jorenby DE, Baker TB.

Addiction. 2011 Feb;106(2):418-27. doi: 10.1111/j.1360-0443.2010.03173.x. Epub 2010 Oct 25.

6.

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.

Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, Baker TB.

Arch Gen Psychiatry. 2009 Nov;66(11):1253-62. doi: 10.1001/archgenpsychiatry.2009.142. Erratum in: Arch Gen Psychiatry. 2010 Jan;67(1):77. Dosage error in article text.

7.

Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.

Kalman D, Herz L, Monti P, Kahler CW, Mooney M, Rodrigues S, O'Connor K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):111-8. doi: 10.1016/j.drugalcdep.2011.03.005. Epub 2011 Apr 19.

8.

Smoking cessation in smokers who smoke menthol and non-menthol cigarettes.

Smith SS, Fiore MC, Baker TB.

Addiction. 2014 Dec;109(12):2107-17. doi: 10.1111/add.12661. Epub 2014 Jul 21.

9.

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, Fiore MC, Rennard SI, Leischow SJ.

Clin Ther. 2001 May;23(5):744-52.

PMID:
11394732
10.

Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation.

Ramon JM, Morchon S, Baena A, Masuet-Aumatell C.

BMC Med. 2014 Oct 8;12:172. doi: 10.1186/s12916-014-0172-8.

11.

Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.

Ebbert JO, Hatsukami DK, Croghan IT, Schroeder DR, Allen SS, Hays JT, Hurt RD.

JAMA. 2014 Jan 8;311(2):155-63. doi: 10.1001/jama.2013.283185.

12.

An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.

Etter JF, Schneider NG.

Nicotine Tob Res. 2013 Jan;15(1):59-68. doi: 10.1093/ntr/nts084. Epub 2012 Apr 22.

PMID:
22529220
13.

Antidepressants for smoking cessation.

Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2014 Jan 8;(1):CD000031. doi: 10.1002/14651858.CD000031.pub4. Review.

PMID:
24402784
14.
15.

Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD.

Melzer AC, Feemster LC, Collins MP, Au DH.

J Hosp Med. 2016 Apr;11(4):257-63. doi: 10.1002/jhm.2519. Epub 2015 Dec 14.

PMID:
26663891
16.

Smoking cessation interventions for smokers with current or past depression.

van der Meer RM, Willemsen MC, Smit F, Cuijpers P.

Cochrane Database Syst Rev. 2013 Aug 21;(8):CD006102. doi: 10.1002/14651858.CD006102.pub2. Review.

PMID:
23963776
17.

Systematic review and meta-analysis of combination therapy for smoking cessation.

Shah SD, Wilken LA, Winkler SR, Lin SJ.

J Am Pharm Assoc (2003). 2008 Sep-Oct;48(5):659-65. doi: 10.1331/JAPhA.2008.07063. Review.

PMID:
18826906
18.

Paths to tobacco abstinence: A repeated-measures latent class analysis.

McCarthy DE, Ebssa L, Witkiewitz K, Shiffman S.

J Consult Clin Psychol. 2015 Aug;83(4):696-708. doi: 10.1037/ccp0000017. Epub 2015 Apr 13.

19.

Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.

Jiménez Ruiz CA, Ramos Pinedo A, Cicero Guerrero A, Mayayo Ulibarri M, Cristobal Fernández M, Lopez Gonzalez G.

Nicotine Tob Res. 2012 Sep;14(9):1035-9. doi: 10.1093/ntr/nts001. Epub 2012 Feb 17.

PMID:
22345320
20.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995

Supplemental Content

Support Center